Abstract:This review highlights recent advancements from 2018 to 2023, emphasizing the therapeutic potential and application of oxazole derivatives, including anticancer, antibacterial, antidiabetic, anticonvulsant, and central nervous system (CNS)‐modulating effects. Key findings include their roles in enzyme inhibition, antitumor activity, phosphodiesterase inhibition, and neuroprotective properties. The review also discusses the most potent compounds, their mechanisms of action, and their therapeutic relevance across various diseases, providing insights into the future development of oxazole‐based therapies. Oxazole, a five‐membered cyclic ring containing oxygen and nitrogen, displays diverse interactions and structural variations, enhancing its potential applications across various domains. Oxazole derivatives exhibit diverse pharmacological activities, including antidiabetic, anticonvulsant, anticancer, phosphodiesterase inhibition, antiprotozoal, and antibacterial effects, making them appealing to medicinal chemists. Their presence in naturally occurring pharmacologically active substances as well as synthetic medicines underscores their therapeutic potential. This review encompasses recent advancements in the biological activities of oxazole derivatives during the period of 2018–2023. The discussed activities include antitumor, central nervous system (CNS) modulation, antidiabetic, anti‐Alzheimer, antibacterial, and enzyme inhibitory effects. The review highlights the mechanisms of action of these compounds in various diseases, the most potent compounds along with their respective IC50/MIC (inhibitory concentration/minimum inhibitory concentration) values, and discusses the models utilized for quantifying their activity. Currently, there are eight FDA‐approved drugs bearing oxazole scaffolds available in the market. Analysis of the literature reveals that the antitumor activity of oxazole derivatives is particularly noteworthy among their various activities. The incorporation of phenyl, methoxyphenyl, or halogen‐substituted phenyl moieties significantly enhances therapeutic activities compared to reference drugs. The substitution flexibility at three positions of oxazole derivatives contributes to their spectrum of pharmacological activities.

Oxazole: A Promising Building Block for the Development of Potent Antitumor Agents.

Oxazole-based compounds as anticancer agents.

Synthesis and biological activity of novel 1,3,4-oxadiazole derivatives containing a pyrazole moiety

1,3,4-Oxadiazole Derivatives As Potential Antitumor Agents: Discovery, Optimization and Biological Activity Valuation

1,3,4-Oxadiazole Derivatives As Potential Biological Agents

Review on Therapeutic Diversity of Oxazole Scaffold: An Update

Synthesis and Antitumor Activity of 2-Aryl-1, 2, 4-Triazolo[1, 5-A] Pyridine Derivatives

New Oxazolo[5,4- d]pyrimidines as Potential Anticancer Agents: Their Design, Synthesis, and In Vitro Biological Activity Research

Synthesis and in vitro anticancer evaluation of functionalized 5-(4-piperazin-1-yl)-2-aryloxazoles and 5-[(4-arylsulfonyl)piperazin-1-yl]-2-phenyloxazoles

Synthesis, Characterization, and in Vitro Anticancer Evaluation of 2-Aryl-4-Arylsulfonyl-5-RS-1,3-Oxazoles

Recent Advances in the Development of Pyrazole Derivatives as Anticancer Agents

Novel 2,4,5-Trisubstituted Oxazole Derivatives: Synthesis and Antiproliferative Activity

Novel Penta-1,4-Diene-3-One Derivatives Containing Quinazoline And Oxime Ether Fragments: Design, Synthesis And Bioactivity

Synthesis and Biological Potentials of 5-aryl-N-[4-(trifluoromethyl) phenyl]-1,3,4-oxadiazol-2-amines

The Fundamental Role of Oxime and Oxime Ether Moieties in Improving the Physicochemical and Anticancer Properties of Structurally Diverse Scaffolds

Novel 5-Methyl-2,4-disubstitued-oxazole Derivatives: Synthesis and Anticancer Activity

Pyrazole Derivatives As Antitumor, Anti-Inflammatory and Antibacterial Agents

A comprehensive review on biological activities of oxazole derivatives

Synthesis, Molecular Modeling and Biological Evaluation of 2-Aminomethyl-5-(quinolin-2-yl)-1,3,4-oxadiazole-2(3h)-thione Quinolone Derivatives As Novel Anticancer Agent

Natural and synthetic 5‐(3′‐indolyl)oxazoles: Biological activity, chemical synthesis and advanced molecules

Synthesis, Molecular Modeling, and Biological Evaluation of Quinazoline Derivatives Containing the 1,3,4-Oxadiazole Scaffold As Novel Inhibitors of VEGFR2